A lot of ‘world firsts’ are involved in an Australian clinical trial that is taking a precision medicine approach to treating CMML, a neglected and serious rare blood cancer that is poorly understood.
Dr Devendra Hiwase thinks every patient with this rare form of blood cancer should have molecular profiling.
Tony Wakely shares his personal journal, where he documents his experiences with MDS and AML.
The treatment for newly diagnosed MDS will be available “very soon” to Australians in a clinical trial.
The Australian Familial Haematological Cancer Study (AFHCS) leads the world in the field and has a research cohort of more than 200 families with a history of blood cancer.
After losing her dad to MDS, and her brother’s diagnosis just a month before hers, Christine Heath’s family underwent genomic testing to understand whether their MDS could be hereditary.
This MDS World Awareness Day, Danny Palmer will celebrate achieving remission after undergoing a life-saving transplant earlier this year. He’s now committed to raising awareness of the many different blood cancers, encouraging others to donate blood and plasma, as well as fundraise in support of the community.
Dr Steven Lane hopes to understand how myelodysplasia (MDS) forms from normal cells.
Amber Walker has relied on fortnightly blood transfusions since being told she had blood cancer for the second time.
Better understanding and treating MDS is the focus of five new research projects that are part of the Leukaemia Foundation’s National Research Program.
